These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16372882)

  • 1. Current status and future prospects for a vaccine against American trypanosomiasis.
    Garg N; Bhatia V
    Expert Rev Vaccines; 2005 Dec; 4(6):867-80. PubMed ID: 16372882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine development against Trypanosoma cruzi and Chagas disease.
    Vázquez-Chagoyán JC; Gupta S; Garg NJ
    Adv Parasitol; 2011; 75():121-46. PubMed ID: 21820554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary approaches to designing and evaluating vaccines against Chlamydia.
    Igietseme JU; Eko FO; Black CM
    Expert Rev Vaccines; 2003 Feb; 2(1):129-46. PubMed ID: 12901604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era.
    Dumonteil E
    Infect Genet Evol; 2009 Dec; 9(6):1075-82. PubMed ID: 19805015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination approaches against Trypanosoma cruzi infection.
    Cazorla SI; Frank FM; Malchiodi EL
    Expert Rev Vaccines; 2009 Jul; 8(7):921-35. PubMed ID: 19538117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
    Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
    Innes EA; Vermeulen AN
    Parasitology; 2006; 133 Suppl():S145-68. PubMed ID: 17274844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine.
    Miyahira Y
    Parasitol Int; 2008 Mar; 57(1):38-48. PubMed ID: 17728174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
    Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity and vaccine development efforts against Trypanosoma cruzi.
    Rios LE; Vázquez-Chagoyán JC; Pacheco AO; Zago MP; Garg NJ
    Acta Trop; 2019 Dec; 200():105168. PubMed ID: 31513763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status and future prospects for a vaccine against schistosomiasis.
    Lebens M; Sun JB; Czerkinsky C; Holmgren J
    Expert Rev Vaccines; 2004 Jun; 3(3):315-28. PubMed ID: 15176948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control.
    Bivona AE; Alberti AS; Cerny N; Trinitario SN; Malchiodi EL
    Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165658. PubMed ID: 31904415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library.
    Tekiel V; Alba-Soto CD; González Cappa SM; Postan M; Sánchez DO
    Vaccine; 2009 Feb; 27(9):1323-32. PubMed ID: 19162108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of vaccination in Chagas disease revisited.
    Camargo EP
    Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():275-80. PubMed ID: 19753485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Vaccines against Chagas Disease: A Journey through History.
    Rodríguez-Morales O; Monteón-Padilla V; Carrillo-Sánchez SC; Rios-Castro M; Martínez-Cruz M; Carabarin-Lima A; Arce-Fonseca M
    J Immunol Res; 2015; 2015():489758. PubMed ID: 26090490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protection of mice with Trypanosoma lewisi antigen and its fractions against experimental Trypanosoma cruzi infection].
    Fernández de Lara WG
    Rev Inst Med Trop Sao Paulo; 1972; 14(5):301-5. PubMed ID: 4630386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.